英文著書 | 英文論文 | 和文論文

 

ウイルス第一部　発表論文（2019年）

 

英文著書
  1. Saijo M. Introduction. In Severe Fever with Thrombocytopenia Syndrome. Ed. Masayuki Saijo, pp1-14, 2019, Singapore
  2. Kato H, Saijo M. Epidemiology of SFTS in China. In Severe Fever with Thrombocytopenia Syndrome. Ed. Masayuki Saijo, pp71-94, 2019, Singapore
  3. Shimada T, Saijo M, Oishi K. Epidemiology of SFTS in Japan. In Severe Fever with Thrombocytopenia Syndrome. Ed. Masayuki Saijo, pp103-108, 2019, Singapore
  4. Saijo M. Pathology of severe fever with thrombocytopenia syndrome. In Severe Fever with Thrombocytopenia Syndrome. Ed. Masayuki Saijo, pp 137-150, 2019, Singapore
  5. Saijo M. Animal experimental models for the study on severe fever with thrombocytopenia syndrome virus infection. In Severe Fever with Thrombocytopenia Syndrome. Ed. Masayuki Saijo, pp 215-230, 2019, Singapore
  6. Saijo M. Circulation of severe fever with thrombocytopenia syndrome virus (SFTSV) in nature: transmission of SFTSV between mammals and ticks. In Severe Fever with Thrombocytopenia Syndrome. Ed. Masayuki Saijo, pp 151-173, 2019, Singapore
  7. Tani H, Saijo M. Antiviral drugs for the therapeutics of SFTS. In Severe Fever with Thrombocytopenia Syndrome. Ed. Masayuki Saijo, pp185-196, 2019, Singapore
  8. Fukushi S. Seroprevalence and risk factors of severe fever with thrombocytopenia syndrome. Ed. Masayuki Saijo, pp109-120, 2019, Singapore
  9. Shimojima M. Similarity and difference in characteristics of two diseases, SFTS and CCHF, and their causative agents. Ed. Masayuki Saijo, pp231-246, 2019, Singapore

 

 

英文論文
  1. Eto A, Fujita M, Nishiyama Y, Saito T, Molina DM, Morikawa S, Saijo M, Shinmura Y, Kanatani Y. Profiling of the antibody response to attenuated LC16m8 smallpox vaccine using protein array analysis. Vaccine. 2019;37(44):6588-6593. doi: 10.1016/j.vaccine.2019.09.006.
  2. Fujii H, Harada S, Yoshikawa T, Yamada S, Omura N, Shibamura M, Inagaki T, Kato H, Fukushi S, Saijo M. Differences in the likelihood of acyclovir resistance-associated mutations in the thymidine kinase genes of herpes simplex virus 1 and varicella-zoster virus. Antimicrob Agents Chemother. 2019;63(5). pii: e00017-19. doi: 10.1128/AAC.00017-19.
  3. Hishiki T, Kato F, Nio Y, Watanabe S, Wen Tan NW, Yamane D, Miyazaki Y, Lin CC, Suzuki R, Tajima S, Lim CK, Saijo M, Hijikata M, Vasudevan SG, Takasaki T. Stearoyl-CoA desaturase-1 is required for flavivirus RNA replication. Antiviral Res. 2019;165:42-46. doi: 10.1016/j.antiviral.2019.03.002.
  4. Hobson-Peters J, Harrison JJ, Watterson D, Hazlewood JE, Vet LJ, Newton ND, Warrilow D, Colmant AMG, Taylor C, Huang B, Piyasena TBH, Chow WK, Setoh YX, Tang B, Nakayama E, Yan K, Amarilla AA, Wheatley S, Moore PR, Finger M, Kurucz N, Modhiran N, Young PR, Khromykh AA, Bielefeldt-Ohmann H, Suhrbier A, Hall RA. A recombinant platform for flavivirus vaccines and diagnostics using chimeras of a new insect-specific virus. Sci Transl Med. 2019;11(522). pii: eaax7888.
  5. Ishii K, Yamamoto F, Homma S, Okada Y, Nakamichi K, Saijo M, Tamaoka A. Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review. BMC Neurol. 2019;19(1):263. doi: 10.1186/s12883-019-1493-1.
  6. Kato F, Nio Y, Yagasaki K, Suzuki R, Hijikata M, Miura T, Miyazaki I, Tajima S, Lim CK, Saijo M, Takasaki T, Hishiki T. Identification of inhibitors of dengue viral replication using replicon cells expressing secretory luciferase. Antiviral Res. 2019;172:104643. doi: 10.1016/j.antiviral.2019.104643.
  7. Kato H, Takayama-Ito M, Iizuka-Shiota I, Fukushi S, Posadas-Herrera G, Horiya M, Satoh M, Yoshikawa T, Yamada S, Harada S, Fujii H, Shibamura M, Inagaki T, Morimoto K, Saijo M, Lim CK. Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice. PLoS One. 2019;14(10):e0223684. doi: 10.1371/journal.pone.0223684.
  8. Kanai Y, Kawagishi T, Sakai Y, Nouda R, Shimojima M, Saijo M, Matsuura Y, Kobayashi T. Cell-cell fusion induced by reovirus FAST proteins enhances replication and pathogenicity of non-enveloped dsRNA viruses. PLoS Pathog. 2019;15(4):e1007675. doi: 10.1371/journal.ppat.1007675.
  9. Kawai Y, Nakayama E, Takahashi K, Taniguchi S, Shibasaki KI, Kato F, Maeki T, Suzuki T, Tajima S, Saijo M, Lim CK. Increased growth ability and pathogenicity of American- and Pacific-subtype Zika virus (ZIKV) strains compared with a Southeast Asian-subtype ZIKV strain. PLoS Negl Trop Dis. 2019;13(6):e0007387. doi: 10.1371/journal.pntd.0007387.
  10. Kasama K, Fujita H, Yamamoto S, Ooka T, Gotoh Y, Ogura Y, Ando S, Hayash T. Genomic features of Rickettsia heilongjiangensis revealed by intraspecies comparison and detailed comparison with Rickettsia japonica. Front Microbiol. 2019 Dec 6;10:2787.
  11. Kyaw AK, Ngwe Tun MM, Nabeshima T, Buerano CC, Ando T, Inoue S, Hayasaka D, Lim CK, Saijo M, Thu HM, Thant KZ, Morita K. Japanese Encephalitis- and Dengue-Associated Acute Encephalitis Syndrome Cases in Myanmar. Am J Trop Med Hyg. 2019;100(3):643-646. doi: 10.4269/ajtmh.18-0530.
  12. Nosaki Y, Ohyama K, Watanabe M, Yokoi T, Nakamichi K, Saijo M, Miura Y, Iwai K. Simultaneous development of progressive multifocal leukoencephalopathy and cryptococcal meningitis during methotrexate and infliximab treatment. Intern Med. 2019;58(18):2703-2709. doi: 10.2169/internalmedicine.2570-18.
  13. Nakamichi K, Kawamoto M, Ishii J, Saijo M. Improving detection of JC virus by ultrafiltration of cerebrospinal fluid before polymerase chain reaction for the diagnosis of progressive multifocal leukoencephalopathy. BMC Neurol. 2019;19(1):252. doi: 10.1186/s12883-019-1476-2.
  14. Nguyen TTT, Tajima S, Ikeda M, Nguyen TT, Le TTH, Pham HTT, Pham DQ, Le MTQ, Maeki T, Taniguchi S, Kato F, Moi ML, Morita K, Lim CK, Saijo M, Hasebe F. Neutralization potency of sera from Vietnamese patients with Japanese encephalitis (JE) against genotypes I and V JE viruses. Jpn J Infect Dis. 2019;72(2):115-117. doi: 10.7883/yoken.JJID.2018.232.
  15. Nishigori R, Warabi Y, Shishido-Hara Y, Nakamichi K, Nakata Y, Komori T, Isozaki E. Inflammatory cerebellar PML with a CD4/CD8 ratio of 2.9 showed a favorable prognosis in a patient with rheumatoid arthritis: A Case Report. Intern Med. 2019;58(22):3323-3329.
  16. Matsui T, Kinoshita N, Maeki T, Kutsuna S, Nakamura K, Nakamoto T, Ishikane M, Tajima S, Kato F, Taniguchi S, Lim CK, Saijo M, Ohmagari N. Dengue virus type 2 infection in a traveler returning from Saudi Arabia to Japan. Jpn J Infect Dis. 2019;72(5):340-342. doi: 10.7883/yoken.JJID.2018.537.
  17. Maeki T, Tajima S, Ikeda M, Kato F, Taniguchi S, Nakayama E, Takasaki T, Lim CK, Saijo M. Analysis of cross-reactivity between flaviviruses with sera of patients with Japanese encephalitis showed the importance of neutralization tests for the diagnosis of Japanese encephalitis. J Infect Chemother. 2019;25(10):786-790. doi: 10.1016/j.jiac.2019.04.003.
  18. Oluwayelu D, Afrough B, Adebiyi A, Varghese A, Eun-Sil P, Fukushi S, Yoshikawa T, Saijo M, Neumann E, Morikawa S, Hewson R, Tomori O. Prevalence of antibodies to Crimean-Congo hemorrhagic fever virus in ruminants, Nigeria, 2015. Emerg Infect Dis. 2020;26(4):744-747. doi: 10.3201/eid2604.190354.
  19. Park ES, Shimojima M, Nagata N, Ami Y, Yoshikawa T, Iwata-Yoshikawa N, Fukushi S, Watanabe S, Kurosu T, Kataoka M, Okutani A, Kimura M, Imaoka K, Hanaki K, Suzuki T, Hasegawa H, Saijo M, Maeda K, Morikawa S. Severe fever with thrombocytopenia syndrome phlebovirus causes lethal viral hemorrhagic fever in cats. Sci Rep. 2019;9(1):11990. doi: 10.1038/s41598-019-48317-8.
  20. Prow NA, Hirata TDC, Tang B, Larcher T, Mukhopadhyay P, Alves TL, Le TT, Gardner J, Poo YS, Nakayama E, Lutzky VP, Nakaya HI, Suhrbier A. Exacerbation of Chikungunya virus rheumatic immunopathology by a high fiber diet and butyrate. Front Immunol. 2019;10:2736.
  21. Sakata M, Katoh H, Otsuki N, Okamoto K, Nakatsu Y, Lim CK, Saijo M, Takeda M, Mori Y. Heat Shock Protein 90 Ensures the Integrity of Rubella Virus p150 Protein and Supports Viral Replication. J Virol. 2019;93(22). pii: e01142-19. doi: 10.1128/JVI.01142-19.
  22. Satoh M, Kato H, Takayama-Ito M, Ogawa M, Ando S, Saijo M. In vitro evaluation of minimum inhibitory concentration of several antibacterial agents against Rickettsia japonica using a plaque reduction assay system. J Infect Chemother. 2019;25(11):917-919. doi: 10.1016/j.jiac.2019.05.019.
  23. Setoh YX, Amarilla AA, Peng NYG, Griffiths RE, Carrera J, Freney ME, Nakayama E, Ogawa S, Watterson D, Modhiran N, Nanyonga FE, Torres FJ, Slonchak A, Periasamy P, Prow NA, Tang B, Harrison J, Hobson-Peters J, Cuddihy T, Cooper-White J, Hall RA, Young PR, Mackenzie JM, Wolvetang E, Bloom JD, Suhrbier A, Khromykh AA. Determinants of Zika virus host tropism uncovered by deep mutational scanning. Nat Microbiol. 2019;4(5):876-887.
  24. Schroder WA, Hirata TD, Le TT, Gardner J, Boyle GM, Ellis J, Nakayama E, Pathirana D, Nakaya HI, Suhrbier A. SerpinB2 inhibits migration and promotes a resolution phase signature in large peritoneal macrophages. Sci Rep. 2019;9(1):12421.
  25. Shimada M, Takamoto N, Su H, Sasahara H, Shimamura Y, Ando S, Ohashi N. Predomination shift of different P44-expressing Anaplasma phagocytophilum in infected HL-60, THP-1, NB4, and RF/6A cell lines. Jpn J Infect Dis. 72:73-80, 201.
  26. Shiota T, Li TC, Nishimura Y, Yoshizaki S, Sugiyama R, Shimojima M, Saijo M, Shimizu H, Suzuki R, Wakita T, Muramatsu M, Ishii K. Integrin α3 is involved in non-enveloped hepatitis E virus infection. Virology. 2019;536:119-124. doi: 10.1016/j.virol.2019.07.025.
  27. Su H, Ito K, Kawarasaki Y, Morita H, Nose H, Iketa K, Nakadouzono F, Gokuden M, Kamiyama S, Tokaji A, Rikitake Y, Kawaguchi T, Umekita K, Oishi S, Abe F, Kanda T, Kawabata H, Ando S, Ohashi N. Insight of diagnostic performance using B-cell epitope antigens derived from triple P44-related proteins of Anaplasma phagocytophilum. Diagn Microbiol Infect Dis. 95(2):125-130, 201.
  28. Tani H, Kawachi K, Kimura M, Taniguchi S, Shimojima M, Fukushi S, Igarashi M, Morikawa S, Saijo M. Identification of the amino acid residue important for fusion of severe fever with thrombocytopenia syndrome virus glycoprotein. Virology. 2019;535:102-110. doi: 10.1016/j.virol.2019.06.014.
  29. Tajima S, Shibasaki KI, Taniguchi S, Nakayama E, Maeki T, Lim CK, Saijo M. E　and prM proteins of genotype V Japanese encephalitis virus are required for its increased virulence in mice. Heliyon. 2019;5(11):e02882. doi: 10.1016/j.heliyon.2019.e02882.
  30. Taira M, Ando S, Kawabata H, Fujita H, Kadosaka T, Sato H, Monma N, Ohashi N, Saijo M. Isolation and molecular detection of Ehrlichia species from ticks in western, central, and eastern Japan. Ticks Tick Borne Dis. 2019;10(2):344-351. doi: 10.1016/j.ttbdis.2018.11.010.
  31. Tohma D, Tajima S, Kato F, Sato H, Kakisaka M, Hishiki T, Kataoka M, Takeyama H, Lim CK, Aida Y, Saijo M. An estrogen antagonist, cyclofenil, has anti-dengue-virus activity. Arch Virol. 2019;164(1):225-234. doi: 10.1007/s00705-018-4079-0.
  32. Yamagishi T, Kakimoto K, Doi I, Kawakami C, Shimada T, Matsui T, Oishi K, Saijo M. Transmission routes of the virus causing viral hemorrhagic fever: Extreme precautions are prudent but high-quality evidence must be gathered. Infect Control Hosp Epidemiol. 2019;40(5):608-609. doi: 10.1017/ice.2019.46.

 

 

和文論文
  1. 小林祐介，島田智恵，山岸拓也，松井珠乃，下島昌幸，西條政幸，大石和徳．日本におけるSFTS患者の疫学：2017年現在．IASR40:113-114, 2019
  2. 神田宏平，木下典子，奥濱絢乃，中村啓二，下村暁，稲垣剛志，忽那賢志，大曲貴夫，下島昌幸，西條政幸．東京都で初めて重症熱性血小板減少症候群と診断された症例．IASR40:114-115, 2019
  3. 西條政幸．鶴政俊，大島寛彰，奥村博信，前田健．ペットからSFTSウイルスに感染し，SFTSを発症した事例報告．IASR40:117-118, 2019
  4. 安川正貴，西條政幸．SFTSに対するファビピラビル治療効果を調べるための医師主導型臨床研究．IASR40:121, 2019
  5. 西條政幸．免疫不全患者における薬剤耐性単純ヘルペスウイルス感染症と対策．Precision Medicine 2:872-878, 2019
  6. 加藤博史、西條政幸．重症熱性血小板減少症候群（SFTS）の現状．アステラス．
  7. 西條政幸．注目すべき新興感染症はありますでしょうか．インフルエンザとその他の呼吸器感染症．20:151, 2019
  8. 西條政幸．SFTS，クリミア・コンゴ出血熱．最新医学 74:483-489, 2019
  9. 西條政幸，安田二朗，平山謙二．BSL-4施設の重要性と世界への貢献．最新医学 74:453-463, 2019
  10. 西條政幸．もしも，国内でエボラウイルス病患者が発生したら？臨床とウイルス 47:391-395, 2019
  11. 竹腰顕，吉倉延亮，小澤憲司，生駒良和，北川順一，竹島明，大槻美佳，中道一生，西條政幸，大江直行，望月清文，柿田明美，下畑亨良．経過中にBalint症候群を発症し，塩酸目風呂菌とミルタザピンの併用療法により改善した進行性多巣性白質脳症の1例．Brain and Nerve 71:281-286, 2019
  12. 伊藤（高山）睦代. 狂犬病. Neuroinfection. 24(2), 113-117, 2019
  13. 伊藤（高山）睦代. 医療（臓器移植，輸血）関連動物由来ウ イルス感染症. グ ローバル時代のウイルス感染症. 226-231, 2019
  14. 佐藤（大久保）梢，高野愛，高娃，安藤秀二，川端寛樹．ダニ媒介性感染症-国内に常在する感染症を主に-．衛生動物学会MiniReview集「シリーズ：ダニ研究の最前線とダニ媒介性感染症の可能性を探る」，衛生動物，70(1):3-14, 2019

 

Copyright 1998 National Institute of Infectious Diseases, Japan